PSNL

Personalis, Inc. is a pioneering leader in the cancer genomics field, offering advanced genomic sequencing and analysis that empowers personalized cancer therapies. Based in Menlo Park, California, the company utilizes its proprietary technology platform to generate high-quality genomic data, enhancing precision medicine initiatives and supporting healthcare professionals in making informed treatment decisions. With a robust and expanding portfolio of innovative solutions, Personalis is strategically positioned to revolutionize cancer care through its commitment to personalized, data-driven approaches in oncology.